(Q40547815)

English

Design, synthesis, and biological evaluation of aminoboronic acids as growth-factor receptor inhibitors of EGFR and VEGFR-1 tyrosine kinases

scientific article published on April 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Design, synthesis, and biological evaluation of aminoboronic acids as growth-factor receptor inhibitors of EGFR and VEGFR-1 tyrosine kinases (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Hiroyuki Nakamura

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

author name string

Toru Asano

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Yoshimasa Uehara

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Yoshinori Yamamoto

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 April 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

483-490

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Episelection: novel Ki approximately nanomolar inhibitors of serine proteases selected by binding or chemistry on an enzyme surface

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200300748

21 January 2018

Potentially Macrocyclic Peptidyl Boronic Acids as Chymotrypsin Inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200300748

21 January 2018

Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200300748

21 January 2018

Protease inhibitors: current status and future prospects

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200300748

21 January 2018

The Chemistry of Neutron Capture Therapy

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200300748

21 January 2018

Growth factors and cancer

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200300748

21 January 2018

Tyrosine kinase inhibition: an approach to drug development

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200300748

21 January 2018

Protein tyrosine kinase inhibitors as novel therapeutic agents

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200300748

21 January 2018

Strategies toward the design of novel and selective protein tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200300748

21 January 2018

Small molecule inhibitors of tumor-promoted angiogenesis, including protein tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200300748

21 January 2018

Oncogenic kinase signalling

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200300748

21 January 2018

Chemical inhibitors of protein kinases

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200300748

21 January 2018

Novel antiproliferative agents derived from lavendustin A.

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200300748

21 January 2018

Design, synthesis, and biological evaluation of a series of lavendustin A analogues that inhibit EGFR and Syk tyrosine kinases, as well as tubulin polymerization

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200300748

21 January 2018

Synthesis and investigation of conformationally restricted analogues of lavendustin A as cytotoxic inhibitors of tubulin polymerization

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200300748

21 January 2018

Method for simultaneous detection of protein kinase A, protein kinase C, protein tyrosine kinase, and calmodulin-dependent protein kinase activities

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200300748

21 January 2018

1a-docosahexaenoyl mitomycin C: a novel inhibitor of protein tyrosine kinase

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200300748

21 January 2018

Synthesis of Carboranes Containing an Azulene Framework andin VitroEvaluation as Boron Carriers

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200300748

21 January 2018

A Practical Method for the Synthesis of Enantiomerically Pure 4-Borono-L-phenylalanine

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200300748

21 January 2018

2-phenylethaneboronic acid, a possible transition-state analog for chymotrypsin

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200300748

21 January 2018

Isolation of a novel tyrosine kinase inhibitor, lavendustin A, from Streptomyces griseolavendus

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200300748

21 January 2018

Synthesis and structure-activity studies of a series of [(hydroxybenzyl)amino]salicylates as inhibitors of EGF receptor-associated tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200300748

21 January 2018

Structure-activity relationships in a series of 5-[(2,5-dihydroxybenzyl)amino]salicylate inhibitors of EGF-receptor-associated tyrosine kinase: importance of additional hydrophobic aromatic interactions

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200300748

21 January 2018

Asymmetric alkyldifluoroboranes and their use in secondary amine synthesis.

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200300748

21 January 2018

Design of new inhibitors for cdc2 kinase based on a multiple pseudosubstrate structure

1 reference

https://api.crossref.org/works/10.1002%2FCBIC.200300748

21 January 2018

Identifiers

10.1002/CBIC.200300748

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40547815&oldid=2096590796"